DOCSLIB.ORG

Characterization of D-Sorbitol Dehydrogenase Involved in D-Sorbitol Production of a Methanol Yeast, Candida Boidinii (Kloeckera Sp.) No

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Characterization of D-Sorbitol Dehydrogenase Involved in D-Sorbitol Production of a Methanol Yeast, Candida Boidinii (Kloeckera Sp.) No Agric. Biol. Chern., 52 (2), 419-426, 1988 419 Characterization of D-Sorbitol Dehydrogenase Involved in D-Sorbitol Production of a Methanol Yeast, Candida boidinii (Kloeckera sp.) No. 2201 Vitchuporn Vongsuvanlert* and Yoshiki Tani Research Center for Cell and Tissue Culture, Faculty of Agriculture, Kyoto University, Kyoto 606, Japan Received August 18, 1987 D-Sorbitol (sorbitol) production from D-glucose could be achieved by initial isomerization of D-glucoseto D-fructose via xylose isomerase, then reduction to sorbitol via sorbitol dehydrogenase coupled with NADHregeneration from the methanol oxidative enzymes system by an intact cell system of a methanol yeast, Candida boidinii (Kloeckera sp.) No. 2201. Sorbitol dehydrogenase was purified 351-fold from a cell-free extract of D-xylose-grown cells and characterized. It oxidized preferably D-mannitol besides sorbitol, and reduced preferably D-xylulose and D-ribulose, besides D-fructose. Kmvalues for sorbitol and D-fructose were 7.7 and 263mM,and Vmaxvalues were 301 and 384/imol/min/mg, respectively. The enzyme activity was strongly stimulated by Fe3+ and significantly inhibited by Pb2 + , EDTA, and o-phenanthroline. Sorbitol dehydrogenase (SDH) (polyol and the characterization of SDHof C. boidinii dehydrogenase, L-iditol: NAD+-5-oxido- No. 2201, responsible for the reduction of d- reductase, EC 1.1.1.14) is an enzyme which fructose after isomerization of D-glucose. catalyzes the oxidation of sorbitol to D-fruc- tose.1} It is widely distributed among liver MATERIALS AND METHODS and brain of mammals,1 ~9) plant tissues10* and microorganisms, especially bacteria, n ~13) and Chemicals. DEAE-Sephacel, Phenyl-Sepharose CL-4B, Sephadex G-200, and Sephacryl S-300 were purchased that from mammalianliver was extensively from Pharmacia Co., Ltd. D-Xylulose, and D-ribulose purified and characterized. However, only the were obtained from Sigma Chemicals Co., Ltd. and l- metabolic pathway of the enzymes from yeasts iditol from Lab. Sarget Merignac. Other chemicals were were thoroughly investigated.14' 15) Moreover, usual commercial products of analytical grade and used SDHmay be clinically useful in the diagnosis without further purification. of liver diseases.5) We reported glucoamylase production to Microorganism and cultivation. C. boidinii No. 2201, which was selected as the strain for sorbitol production make D-glucose from raw cassava starch.16) In from D-glucose,17) was used. The basal medium was an attempt to further use the D-glucose, composed of 0.4g of NH4C1, 0.1g ofKH2PO4, 0.1g of the production of sorbitol, a sweet polyol, was K2HPO4, 0.05g of MgSO4-7H2O, 0.2g of yeast extract, studied with a system coupled with the oxida- and 0.3g of Polypepton (Daigo) in 100ml of deionized tion of methanol to regenerate NADHfor the water, pH 5.5. The inoculum was prepared by growing reduction of D-glucose by cells of a methanol cells on the basal medium containing 0.5 g of D-glucose in yeast, Candida boidinii {Kloeckera sp). No. a 16.5 x 165-mmtest tube for 24hr at 28°C under recipro- cal shaking at 200rpm, and added at a rate of 1%. 2201.17) In this paper, we describe the mech- Resting cells for sorbitol production was prepared as anism of sorbitol production from D-glucose described previously.17) In preparing cells for enzymatic * On leave from Central Laboratory and Greenhouse Complexes, Kasetsart University, KamphaengseanCampus, Nakhon Pathom 73140, Thailand. 420 V. Vongsuvanlert and Y. Tani study of SDH, yeast was grown on 500ml of the basal Methanol was measured by the method ofTani et al.l9) medium containing 2%(w/v) D-xylose in a 2-1 shaking flask. The cultivation was done at 28°C under reciprocal Purification ofSDH. All purification steps were done at shaking at 200rpm for 45hr. Cells were collected by 4°C and centrifugation was done at 14,000 rpm for 20 min. centrifugation and washed twice with 0.05 mpotassium The buffer was 0.05 mpotassium phosphate buffer, pH 7.0, phosphate buffer, pH 7.0. containing 0.25mMDTTunless otherwise stated. The enzymewas concentrated by ukrafiltration using Amicon Preparation of cell-free extract. The cell paste Was PM-10. suspended in 50 mMpotassium phosphate buffer, pH 7.0, Step 1. Ammoniumsulfate saturation. Solid ammonium containing 0.25 mMdithiothreitol (DTT), and disrupted by sulfate was added to the cell-free extract from 101 of an ultrasonic oscillator (Insonator Kubota Model200 m) culture medium to give 40% saturation (243g/1) with with a constant current at 2A for 45min. After centri- stirring, adjusting the pH to 7.0 with 10% NH4OH fugation the resultant supernatant solution was used as the solution. After this was left for 1 hr, the precipitates that cell-free extract. formed were removed by centrifugation and ammonium sulfate was added to the resultant supernatant up to 80% Assay of enzyme activities. The oxidative activity of saturation (285 g/1). After this was left standing overnight, SDH was measured by the method of Leissing and the precipitates that formed were collected by centrif- Guinness.3) The assay mixture contained 10/miol NAD+, ugation and dissolved in the buffer at a minimumvolume. 50mmol Tris-HCl buffer, pH 9.0, 8.69mmol sorbitol, The enzymesolution was dialyzed against the samebuffer and enzyme solution appropriately diluted with 50mM overnight. Insoluble materials formed during dialysis were potassium phosphate buffer, pH 7.4, containing 0.25 mM removed by centrifugation. DTT, in a total volume of 1.15ml. Initial velocity was Step 2. DEAE-cellulose column chromatography. The measured by the increase in absorbance at 340nm at dialyzed enzyme solution was put on a DEAE-cellulose 30°C due to the reduction of NAD+by monitoring for at column (4.0 x 40cm) equilibrated with 0.05m potassium least 1 min with a Hitachi Model 200 spectrophotometer. phosphate buffer, pH 7.0, containing 0.25 mMDTT. The The reductive activity was measured by the method of elution wasstepwise. The active fractions eluted by 0.1 m Gerlach and Hiby18) through the decrease of absorbance potassium phosphate buffer, pH 7.0, containing 0.1 m at 340mn due to the oxidation of NADH. The assay NaCl, were pooled and concentrated. mixture contained 107 mmolTris-maleate buffer, pH 5.6, Step 3. DEAE-Sephacel column chromatography. The 0.4mmol NADH,400mmol D-fructose, and enzyme so- concentrated enzyme from Step 2 was put on a DEAE- lution in a total volume of 1 ml. One unit of enzymewas Sephacel column (2.5 x 34cm) equilibrated with 0.05m defined as 1 /miol of NADHincreased or decreased per potassium phosphate buffer, pH 7.0, containing 0.25mM min for the oxidative and reductive activities, respec- DTT,and eluted like the DEAE-cellulose column except tively. for a flow rate of 40ml/hr. The active fractions were Alcohol oxidase (AOD) activity was measured by the pooled and concentrated. ABTS/PODmethod as described by Tani et al.l9) The Step 4. Phenyl-Sepharose CL-4B column chromatog- color produced was measured spectrophotometrically at raphy. The concentrated enzyme from Step 3 was put on a 420nm.Oneunit of enzymewas defined as the amount Phenyl-Sepharose CL-4B column (2.5 x 6.0cm) equili- which oxidized 1 ^mol of ABTSper min at 28°C. brated with 3mKC1,and eluted stepwise at a flow rate Formaldehyde dehydrogenase (FAL-DH) activity was of 20ml/hr with 3.0, 1.5, 0.75, and 0m KC1. The enzyme assayed based on the reduction of NAD+as described by was eluted with goodseparation and the active fractions Schiitte et al.20) by following the increase in absorbance at eluted by 0 mKC1were pooled and concentrated. 340nm.Oneunit of enzymewas defined as the amount Step 5. Hydroxyapatite column chromatography. The which produced 1 /rniol of NADHper min at 30°C. concentrated enzyme from Step 4 was put on a hy- Xylose isomerase activity was measured by the method droxyapatite column (2.5 x6.0cm) equilibrated with of Yamanaka21) using D-glucose as substrate. The d- 0.01 Mpotassium phosphate buffer, pH 7.0, containing fructose formedwas measured spectrophotometrically at 0.25 mMDTTand eluted stepwise at a flow rate of20 ml/hr 540nm by the cysteine-carbazole reaction. One unit of with 0.01, 0.05, and 0.1 m potassium phosphate buffer, pH enzyme was defined as the amount which produced 1 7.0, containing 0.25mMDTT. The active fractions were /miol of D-fructose per min at 40°C. pooled and concentrated. Step 6. 1st Sephadex G-200 gel filtration. The con- Analytical methods. Protein was estimated from the centrated enzymefrom Step 5 wasput on a Sephadex G- absorbancy at 280 nm and by the method ofLowry et al.22) 200 column (1.5x85cm) equilibrated with 0.05m po- with bovine serum albumin as the standard. tassium phosphate buffer, pH 7.0, containing 0.25mM Sorbitol was measured enzymatically under the en- DTT.The enzymewas eluted with the same buffer and the dpoint system as described in our previous paper.17) active fractions were pooled and concentrated. D-Sorbitol Dehydrogenase of Methanol Yeast 421 Step 7. 2nd Sephacryl S-300 gel filtration. The con- centrated enzyme from Step 6 was put on a Sephacryl S- 300 column (1.0x85cm) equilibrated with 0.05m pot- assium phosphate buffer, pH 7.0, containing 0.25mM DTT.The enzymewas eluted with the same buffer and the active fractions were pooled. RESULTS EnzymesFigure for1 showssorbitolenzymeproductionactivities fromrelatingglucoseto sorbitol production from D-glucose in cell-free Fig. 1. Enzyme Activities Relating to Sorbitol extracts from different growth phases of cells grown on a mediumcontaining 1%methanol Production in Cells. and 0.3% D-xylose. The enzyme activities pos- Cell-free extracts from different growth phases were pre- sibly involved in sorbitol production, xylose pared from cells grownon the basal mediumsupplement- ed with 1% (v/v) methanol and 0.3% (w/v) xylose.
Load more

Recommended publications
  • Clostridium Difficile Exploits a Host Metabolite Produced During Toxin-Mediated Infection
    bioRxiv preprint doi: https://doi.org/10.1101/2021.01.14.426744; this version posted January 15, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. 1 Clostridium difficile exploits a host metabolite produced during toxin-mediated infection 2 3 Kali M. Pruss and Justin L. Sonnenburg* 4 5 Department of Microbiology & Immunology, Stanford University School of Medicine, Stanford 6 CA, USA 94305 7 *Corresponding author address: [email protected] 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 bioRxiv preprint doi: https://doi.org/10.1101/2021.01.14.426744; this version posted January 15, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. 23 Several enteric pathogens can gain specific metabolic advantages over other members of 24 the microbiota by inducing host pathology and inflammation. The pathogen Clostridium 25 difficile (Cd) is responsible for a toxin-mediated colitis that causes 15,000 deaths in the U.S. 26 yearly1, yet the molecular mechanisms by which Cd benefits from toxin-induced colitis 27 remain understudied. Up to 21% of healthy adults are asymptomatic carriers of toxigenic 28 Cd2, indicating that Cd can persist as part of a healthy microbiota; antibiotic-induced 29 perturbation of the gut ecosystem is associated with transition to toxin-mediated disease.
    [Show full text]
  • Ular Basis of KAISER, S
    Heredity 74 (1995) 267—273 Received6May 1994 OThe Genetical Society of Great Britain 1981. The molecular basis of KAISER, S. 1935. The factorsSOMMER, controlling H. 1991. Genetic shape control ofand flower sizedevelopment in Genetic differentiation among populations of by homeotic genes in Antirrhinum majus. Science, 250, Myopus schisticolor (the wood lemming) — LANDE, R. 1981. The minimumSHORE, number J. S. AND BARRETF, of genes S. C. H. 1990. contributing Quantitative genetics of floral characters in homostylous Turnera ulmifolia var, isozyme variation angustifolia Willd. (Turneraceae). Heredity, 64, LANDE, R, 1983. The responseSINNO1F, to e. w.selection 1935. Evidence onfor the major existence of and genes VADIM B. FEDOROVif, RICKARD FREDRIKSSON1: & KARLFREDGA* SINNO'rr, E. w. 1936. A developmental analysis of inherited t/nstitute of Plant and Animal Ecology, Russian Academy of Sciences, 8 March Street 202, Jekaterinburg 620 008, tion on correlated characters.shape Evolution, differences in Cucurbit37, 1210—1226. fruits. Am. Nat., 70, Russia and Department of Genetics, Uppsa/a University, Box 7003, S-75007Uppsala, Sweden LORD, C. M. AND HILL, .i. i'. 1987. Evidence for heterochrony in Toinvestigate genetic differentiation among populations of the wood lemming Myopus schistico!or (eds) Development as an Evolutiona,ySMITH, H. H. 1950. DevelopmentalProcess, restrictions pp. 47—70. on recombina- (Muridae, Rodentia) isozyme variation in 10 populations from three regions, Fennoscandia, Western and Eastern Siberia, was examined. From 20 loci examined, the two most polymorphic MACNAIR, M. R. AND CUMBES,TAKHTAJAN, o. .i. 1989. A. 1976. The Neoteny genetic and the architectureorigin of flowering ones, Idh-1 and Pgi-1, were used in the complete survey.
    [Show full text]
  • Global Profiling of Metabolic Adaptation to Hypoxic Stress in Human Glioblastoma Cells
    Global profiling of metabolic adaptation to hypoxic stress in human glioblastoma cells. Kucharzewska, Paulina; Christianson, Helena; Belting, Mattias Published in: PLoS ONE DOI: 10.1371/journal.pone.0116740 2015 Link to publication Citation for published version (APA): Kucharzewska, P., Christianson, H., & Belting, M. (2015). Global profiling of metabolic adaptation to hypoxic stress in human glioblastoma cells. PLoS ONE, 10(1), [e0116740]. https://doi.org/10.1371/journal.pone.0116740 Total number of authors: 3 General rights Unless other specific re-use rights are stated the following general rights apply: Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights. • Users may download and print one copy of any publication from the public portal for the purpose of private study or research. • You may not further distribute the material or use it for any profit-making activity or commercial gain • You may freely distribute the URL identifying the publication in the public portal Read more about Creative commons licenses: https://creativecommons.org/licenses/ Take down policy If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim. LUND UNIVERSITY PO Box 117 221 00 Lund +46 46-222 00 00 Download date: 07. Oct. 2021 RESEARCH ARTICLE Global Profiling of Metabolic Adaptation to Hypoxic Stress in Human Glioblastoma Cells Paulina Kucharzewska1, Helena C.
    [Show full text]
  • Polyol Pathway Links Glucose Metabolism to the Aggressiveness
    Published OnlineFirst January 17, 2018; DOI: 10.1158/0008-5472.CAN-17-2834 Cancer Metabolism and Chemical Biology Research Polyol Pathway Links Glucose Metabolism to the Aggressiveness of Cancer Cells Annemarie Schwab1, Aarif Siddiqui1, Maria Eleni Vazakidou1, Francesca Napoli1, Martin Bottcher€ 2, Bianca Menchicchi3, Umar Raza4, Ozge€ Saatci4, Angela M. Krebs5, Fulvia Ferrazzi6, Ida Rapa7, Katja Dettmer-Wilde8, Maximilian J. Waldner3, Arif B. Ekici6, Suhail Ahmed Kabeer Rasheed9, Dimitrios Mougiakakos2, Peter J. Oefner8, Ozgur Sahin4, Marco Volante7, Florian R. Greten10, Thomas Brabletz5, and Paolo Ceppi1 Abstract Cancer cells alter their metabolism to support their malig- sequencing confirmed a profound alteration of EMT in PP- nant properties. In this study, we report that the glucose- deficient cells, revealing a strong repression of TGFb signature transforming polyol pathway (PP) gene aldo-keto-reductase- genes. Excess glucose was found to promote EMT through 1-member-B1 (AKR1B1) strongly correlates with epithelial-to- autocrine TGFb stimulation, while PP-deficient cells were mesenchymal transition (EMT). This association was con- refractory to glucose-induced EMT. These data show that PP firmed in samples from lung cancer patients and from an represents a molecular link between glucose metabolism, can- EMT-driven colon cancer mouse model with p53 deletion. In cer differentiation, and aggressiveness, and may serve as a novel vitro, mesenchymal-like cancer cells showed increased AKR1B1 therapeutic target. levels, and AKR1B1 knockdown was sufficient to revert EMT. An Significance: A glucose-transforming pathway in TGFb-driven equivalent level of EMT suppression was measured by targeting epithelial-to-mesenchymal transition provides novel mecha- the downstream enzyme sorbitol-dehydrogenase (SORD), fur- nistic insights into the metabolic control of cancer differenti- ther pointing at the involvement of the PP.
    [Show full text]
  • Molecular Properties of Membrane-Bound FAD-Containing D-Sorbitol Dehydrogenase from Thermotolerant Gluconobacter Frateurii Isolated from Thailand
    Biosci. Biotechnol. Biochem., 69 (6), 1120–1129, 2005 Molecular Properties of Membrane-Bound FAD-Containing D-Sorbitol Dehydrogenase from Thermotolerant Gluconobacter frateurii Isolated from Thailand y Hirohide TOYAMA,1; Wichai SOEMPHOL,1 Duangtip MOONMANGMEE,2 Osao ADACHI,1 and Kazunobu MATSUSHITA1 1Department of Biological Chemistry, Faculty of Agriculture, Yamaguchi University, Yamaguchi 753-8515, Japan 2Department of Microbiology, Faculty of Science, King Mongkut’s University of Technology Thonburi, Prachauthit Road., Tungkru, Bangkok 10140, Thailand Received December 24, 2004; Accepted March 14, 2005 There are two types of membrane-bound D-sorbitol ism leads to applications in industry for fermentation of dehydrogenase (SLDH) reported: PQQ–SLDH, having valuable products such as L-sorbose, dihydroxyacetone, pyrroloquinoline quinone (PQQ), and FAD–SLDH, D-gluconate, and keto-D-gluconates.3,4) containing FAD and heme c as the prosthetic groups. L-Sorbose is an important intermediate in the indus- FAD–SLDH was purified and characterized from the trial production of vitamin C. The membrane-bound PQQ–SLDH mutant strain of a thermotolerant Gluco- D-sorbitol dehydrogenase (SLDH) has been considered nobacter frateurii, having molecular mass of 61.5 kDa, to play a main role in L-sorbose fermentation.5) In 52 kDa, and 22 kDa. The enzyme properties were quite Gluconobacter strains, two types of membrane-bound similar to those of the enzyme from mesophilic G. oxy- D-sorbitol dehydrogenases have been purified and well dans IFO 3254. This enzyme was shown to be inducible characterized. One was purified from G. suboxydans var by D-sorbitol, but not PQQ–SLDH. The oxidation IFO 32546) as flavohemoprotein, containing a cova- product of FAD–SLDH from D-sorbitol was identified lently bound FAD having three subunits with molecular as L-sorbose.
    [Show full text]
  • Sorbitol Dehydrogenase (SDH) Polyol Dehydrogenase from Sheep Liver L-Iditol: NAD 5´-Oxidoreductase, EC 1.1.1.14
    For life science research only. Not for use in diagnostic procedures. Sorbitol Dehydrogenase (SDH) Polyol dehydrogenase from sheep liver L-Iditol: NAD 5´-oxidoreductase, EC 1.1.1.14 Cat. No. 10 109 339 001 10 mg (60 mg lyo.) y Version 06 Content version: June 2019 Store at +2 to +8°C Product overview • In the colorimetric assay6 of sorbitol and xylitol, high concentrations of reducing substances Ն ␮ Formulation Lyophilizate (12 mg contain 2 mg enzyme protein and ( 5 g/assay) such as ascorbic acid (in fruit juice) 10 mg maltose; 60 mg contain 10 mg enzyme protein or SO2 (in jam) interfere. A procedure for removing and 50 mg maltose). these reducing substances (with H2O2 and alkali) is given in reference6. Contaminants ADH < 0.01%, GIDH < 0.02%, glucose dehydrogenase < 0.02%, Analysis Information LDH < 0.05%, MDH < 0.05% Quality Control Mr 115,000 SDH Substrate Sorbitol dehydrogenase (SDH) will oxidize D-sorbitol to D-fructose + NADH + H+ D-sorbitol + specificity, relative fructose (Km = 0.7 mM; relative rate = 1.00). The + NAD rates and Km enzyme will also oxidize many other polyols, including L-iditiol to L-sorbose (rate = 0.96), xylitol to D-xylulose (rate = 0.85), ribitol to D-ribulose (rate = 0.49) and Unit definition One unit (U) sorbitol dehydrogenase will reduce allitol to allulose (rate = 0.45). SDH also catalyzes the 1 ␮mol of D-fructose in 1 min at 25° C and pH 7.6 reverse (reduction) reactions of each of the above. The [triethanolamine buffer; 150 mM fructose (non- Km for fructose is 250-300 mM.
    [Show full text]
  • Polyol Pathway Links Glucose Metabolism to the Aggressiveness of Cancer Cells
    Author Manuscript Published OnlineFirst on January 17, 2018; DOI: 10.1158/0008-5472.CAN-17-2834 Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. Polyol pathway links glucose metabolism to the aggressiveness of cancer cells. Annemarie Schwab1, Aarif Siddiqui1, Maria Eleni Vazakidou1, Francesca Napoli1, Martin Böttcher2, Bianca Menchicchi3, Umar Raza4, Özge Saatci4, Angela M. Krebs5, Fulvia Ferrazzi6, Ida Rapa7, Katja Dettmer-Wilde8, Maximilian J. Waldner3, Arif B. Ekici6, Suhail Ahmed Kabeer Rasheed9, Dimitrios Mougiakakos2, Peter J. Oefner8, Ozgur Sahin4, Marco Volante7, Florian R. Greten10, Thomas Brabletz5 and Paolo Ceppi1*. Authors affiliations: 1. Junior Research Group 1, Interdisciplinary Center for Clinical Research, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Erlangen, Germany. 2. Department of Internal Medicine 5, Hematology and Oncology, University Hospital Erlangen, Erlangen, Germany; 3. Department of Medicine 1, University Hospital Erlangen, Erlangen, Germany; 4. Bilkent University, Department of Molecular Biology and Genetics, Ankara, Turkey. 5. Experimental Medicine I, FAU Erlangen-Nürnberg, Erlangen, Germany; 6. Institute of Human Genetics, Friedrich-Alexander-Universität Erlangen- Nürnberg, Erlangen, Germany. 7. Pathology Unit, San Luigi Hospital, University of Turin, Turin, Italy; 8. Institute of Functional Genomics University of Regensburg, Regensburg, Germany 9. Duke-NUS Medical School, Singapore; 10. Georg-Speyer-Haus, Institute for Tumor Biology and Experimental Therapy, Frankfurt am Main, Germany * Address correspondence to: Dr. Paolo Ceppi, Junior Research Group 1, Interdisciplinary Center for Clinical Research, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Nikolaus-Fiebiger-Zentrum, Glückstrasse 6, 91054 Erlangen, Germany. tel: +49 (0)91318539300, fax: +49 (0)91318536386 Conflict of interest: The authors declare no conflicts of interests.
    [Show full text]
  • NIH Public Access Author Manuscript Mitochondrion
    NIH Public Access Author Manuscript Mitochondrion. Author manuscript; available in PMC 2012 November 01. NIH-PA Author ManuscriptPublished NIH-PA Author Manuscript in final edited NIH-PA Author Manuscript form as: Mitochondrion. 2011 November ; 11(6): 845–854. doi:10.1016/j.mito.2011.06.007. Nutrient excess and altered mitochondrial proteome and function contribute to neurodegeneration in diabetes Subir K. Roy Chowdhurya,*, Rick T. Dobrowskyb, and Paul Fernyhougha,c aDivision of Neurodegenerative Disorders, St Boniface Hospital Research Centre, Winnipeg, MB, Canada R2H 2A6 bDepartment of Pharmacology & Toxicology, University of Kansas, Lawrence, KS 660 45, USA cDepartment of Pharmacology & Therapeutics, University of Manitoba, Winnipeg, MB, Canada R3E 0T6 Abstract Diabetic neuropathy is a major complication of diabetes that results in the progressive deterioration of the sensory nervous system. Mitochondrial dysfunction has been proposed to play an important role in the pathogenesis of the neurodegeneration observed in diabetic neuropathy. Our recent work has shown that mitochondrial dysfunction occurs in dorsal root ganglia (DRG) sensory neurons in streptozotocin (STZ) induced diabetic rodents. In neurons, the nutrient excess associated with prolonged diabetes may trigger a switching off of AMP kinase (AMPK) and/or silent information regulator T1 (SIRT1) signaling leading to impaired peroxisome proliferator- activated receptor γ coactivator-1α (PGC-1α expression/activity and diminished mitochondrial activity. This review briefly summarizes the alterations of mitochondrial function and proteome in sensory neurons of STZ-diabetic rodents. We also discuss the possible involvement of AMPK/ SIRT/PGC-1α pathway in other diabetic models and different tissues affected by diabetes. Keywords Mitochondrial respiratory chain; Diabetic neuropathy; Dorsal root ganglia; PGC-1α; AMPK; SIRT 1.
    [Show full text]
  • Detection and Characterization of Sorbitol Dehydrogenase from Apple Callus Tissue" 2 Received for Publication November 27, 1978 and in Revised Form February 28, 1979
    Plant Physiol. (1979) 64, 69-73 0032-0889/79/64/0069/05/$00.50/0 Detection and Characterization of Sorbitol Dehydrogenase from Apple Callus Tissue" 2 Received for publication November 27, 1978 and in revised form February 28, 1979 FAYEK B. NEGM AND WAYNE H. LOESCHER Department ofHorticulture and Landscape Architecture, Washington State University, Pullman, Washington 99164 Downloaded from https://academic.oup.com/plphys/article/64/1/69/6077558 by guest on 24 September 2021 ABSTRACT provided evidence for the presence of a polyol dehydrogenase (13). Data from labeling studies suggest that sorbitol is synthesized Sorbitol dehydrogenase (L-iditol:NAD' oxidoreductase, EC 1.1.1.14) in the leaf by way of fructose-6-P which is reduced to sorbitol-6- has been detected and characterzed from apple (Maims donestica cv. P and subsequently dephosphorylated (3, 20). Others, however, Granny Smith) mesocarp tissue cultures. The enzyme oxidized sorbitol, have reported the conversion of D-glucose to sorbitol in apple ( 11) xylitol, L-arabitol, ribitol, and L-threitol in the presence of NAD. NADP and plum leaves (1) when [1'CJglucose was used as a substrate. could not replace NAD. Mannitol was slightly oxidized (8% of sorbitol). Studies of breakdown of ['4Clsorbitol in fruit and other tissues Other polyols that did not serve as substrate were galactitoL myo-inositoL indicate that the polyol may be converted to a hexose (1), primarily D-arabitoL erythritol, and glycerol. The dehydrogenase oxidized NADH in fructose (9). the presence of n-fructose or L-sorbose. No detectable activity was ob- Chong and Taper (6) were able to grow apple callus tissue using served with D-tagatose.
    [Show full text]
  • Molecular Interactions and Implications of Aldose Reductase Inhibition by PGA1 and Clinically Used Prostaglandins
    1521-0111/89/1/42–52$25.00 http://dx.doi.org/10.1124/mol.115.100693 MOLECULAR PHARMACOLOGY Mol Pharmacol 89:42–52, January 2016 Copyright ª 2015 by The American Society for Pharmacology and Experimental Therapeutics Molecular Interactions and Implications of Aldose Reductase Inhibition by PGA1 and Clinically Used Prostaglandins Beatriz Díez-Dacal,1 Francisco J. Sánchez-Gómez,1 Pedro A. Sánchez-Murcia, Ivana Milackova, Tahl Zimmerman, Jana Ballekova, Elena García-Martín, José A. G. Agúndez, Severine Gharbi, Federico Gago, Milan Stefek, and Dolores Pérez-Sala Chemical and Physical Biology Department, Centro de Investigaciones Biológicas, Consejo Superior de Investigaciones Científicas, Madrid, Spain (B.D.-D., F.J.S.-G., T.Z., D.P.-S.); Department of Biomedical Sciences, Universidad de Alcalá, Madrid, Spain (P.A.S.-M., F.G.); Institute of Experimental Pharmacology and Toxicology, Slovak Academy of Sciences, Bratislava, Slovakia (I.M., J.B., M.S.); Department of Pharmacology, University of Extremadura, Cáceres, Spain (E.G.-M., J.A.G.A.); Centro Downloaded from Nacional de Biotecnología, Madrid, Spain (S.G.) Received July 6, 2015; accepted October 19, 2015 ABSTRACT Aldose reductase (AKR1B1) is a critical drug target because of which was supported experimentally. Indeed, loss of biotin molpharm.aspetjournals.org its involvement in diabetic complications, inflammation, and label from the AKR1B1-PGA1-B adduct was favored by tumorigenesis. However, to date, development of clinically glutathione, indicating a retro-Michael reaction, which unveils useful inhibitors has been largely unsuccessful. Cyclopente- new implications of cyPG-protein interaction. PGA1 elicited none prostaglandins (cyPGs) are reactive lipid mediators that only marginal inhibition of aldehyde reductase (AKR1A1), bind covalently to proteins and exert anti-inflammatory and considered responsible for the severe adverse effects of many antiproliferative effects in numerous settings.
    [Show full text]
  • Evaluation of the Aldose Reductase Inhibitor Fidarestat on Ischemia-Reperfusion Injury in Rat Retina
    135-142.qxd 20/5/2010 10:19 Ì ™ÂÏ›‰·135 INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE 26: 135-142, 2010 135 Evaluation of the aldose reductase inhibitor fidarestat on ischemia-reperfusion injury in rat retina IRINA G. OBROSOVA1, YURY MAKSIMCHYK1, PAL PACHER2, ELISABET AGARDH4, MAJ-LIS SMITH4, AZZA B. EL-REMESSY3 and CARL-DAVID AGARDH4 1Pennington Biomedical Research Center, Louisiana State University System, Baton Rouge, LA; 2Section on Oxidative Stress Tissue Injury, Laboratory of Physiological Studies, NIH/NIAAA, Bethesda, MD; 3Program in Clinical and Experimental Therapeutics, College of Pharmacy, University of Georgia, Augusta, GA, USA; 4The Department of Clinical Sciences, University Hospital MAS, Lund University, Malmö, Sweden Received February 24, 2010; Accepted March 29, 2010 DOI: 10.3892/ijmm_00000445 Abstract. This study evaluated the effects of retinal ischemia- intermediate accumulation. These changes were prevented or reperfusion (IR) injury and pre-treatment with the potent and alleviated by the AR inhibitor fidarestat. The results identify specific aldose reductase inhibitor fidarestat on apoptosis, AR as an important therapeutic target for diseases involving aldose reductase and sorbitol dehydrogenase expression, sorbitol IR injury, and provide the rationale for development of pathway intermediate concentrations, and oxidative-nitrosative fidarestat and other AR inhibitors. stress. Female Wistar rats were pre-treated with either vehicle (N-methyl-D-glucamine) or fidarestat, 32 mgkg-1d-1 for both, Introduction in the right jugular vein, for 3 consecutive days. A group of vehicle- and fidarestat-treated rats were subjected to 45-min Sorbitol pathway of glucose metabolism consists of two retinal ischemia followed by 24-h reperfusion. Ischemia was reactions, aldose reductase (AR)-catalyzed NADPH-dependent induced 30 min after the last vehicle or fidarestat adminis- reduction of glucose to its sugar alcohol, sorbitol, followed tration.
    [Show full text]
  • Hypoxia-Inducible-Factor Dependent Induction of Netrin-1
    bioRxiv preprint doi: https://doi.org/10.1101/561340; this version posted May 15, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Circadian light-mediated endothelial metabolic reprogramming Yoshimasa Oyama MD, Ph.D.,1* Colleen M. Bartman Ph.D.,1,4* Stephanie Bonney Ph.D.,1,4* J. Scott Lee Ph.D.,1 Lori A. Walker Ph.D.,2 Jun Han Ph.D.,3 Christoph H. Borchers Ph.D.,3 Peter M. Buttrick M.D.,2 Carol M. Aherne Ph.D.1, Nathan Clendenen M.D.,1 Sean P. Colgan Ph.D.1 and Tobias Eckle M.D., Ph.D.1,2,4# *authors contributed equally 1Mucosal Inflammation Program, Departments of Medicine and Anesthesiology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA; 2Division of Cardiology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA, 3Department of Biochemistry and Microbiology, Genome BC Proteomics Centre, University of Victoria, Victoria, BC, Canada; 4Graduate Training Program in Cell Biology, Stem Cells, and Development, University of Colorado Anschutz Medical Campus, Aurora, CO, USA #Correspondence should be addressed to: Tobias Eckle, M.D., Ph.D. Professor of Anesthesiology, Cardiology and Cell Biology Department of Anesthesiology University of Colorado Denver 12700 E 19th Avenue, Mailstop B112, RC 2, Room 7121 Aurora, CO 80045; Office: +1-303-724 -2932 or - 2947, Fax: +1-303-724-2852 Email: [email protected] Short title: Intense light as endothelium-targeting strategy in myocardial ischemia bioRxiv preprint doi: https://doi.org/10.1101/561340; this version posted May 15, 2019.
    [Show full text]